Trials / Completed
CompletedNCT04593420
Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 817 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of the protocol is to describe the proportion of subjects treated continuously with triptorelin during 12 months following treatment initiation. This study will take place at 187 locations (approximately) in France.
Conditions
Timeline
- Start date
- 2020-11-30
- Primary completion
- 2022-12-08
- Completion
- 2022-12-08
- First posted
- 2020-10-20
- Last updated
- 2022-12-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04593420. Inclusion in this directory is not an endorsement.